Novozymes Biopharma announced R-Tech Ueno (Japanese company) will be using Albucult in a dry eye drug. Albucult is albumin, a component of serum (aka autologous serum eyedrops). I've posted about it once or twice in the past. It's also been listed on R-Tech Ueno's site for a long time so I'm not sure why it's news but hopefully it means it's going to get studied, which would be great.

Novozymes Biopharma supplies R-Tech Ueno with Albucult® for use in unique dry eye therapy

November 15, 2011 – Novozymes Biopharma, part of Novozymes A/S world leader in bioinnovation, has announced that its recombinant human albumin, Albucult®, has been selected by R-Tech Ueno for use in a unique treatment for dry eye syndrome....